M D Campion | Search PubMed

PubMed2001

[Access of developing countries to essential drugs: a process of equity].

In the context of the fight against poverty, the access of developing countries to essential drugs mobilizes the international community. It leads to envisage new and intricates politics. If donations or tiered prices are studied, the manufacturing of generics and even of patented drugs through voluntary or compulsory licensing is evoked. At a longer terms, it's the setting of health national politics and industrialisation which are concerned. These new orientations are not without consequence on the global drug market.

Developing Countries↗

PubMed1999

["Frontier" products].

Explore the source record for details and available documents.

Drug Therapy↗

PubMed1995

[The European Union and drugs].

1993 is a mythical year for the European Union which symbolizes at once the Achievement of the Internal market and the entry into force of Treaties of Policy and Economic Union. The European Union makes up, in all respects, a New Deal for Medicinal Products. Indeed, the scientific and technical harmonization is realized now at international level (ICH); the broader community competencies in the fields of Research, Industrial Policy and Environment predict a new positive context for innovation industry and competition probably in accordance with the European Agency. A contrario, the recognition of competences of Member States due to subsidiary in the following matters: Public Health, Social Security allow some flexibility in the interests of consumers, differences being explained by social and cultural behaviour in each Member State.

Drug Industry↗